Bio: David W. Hein
David W. Hein serves as Peter K. Knoefel Endowed Chair of Pharmacology, Professor and Chairman of the Department of Pharmacology & Toxicology, Distinguished University Scholar and Associate University Provost for Strategic Planning at the University of Louisville (UofL). He also directs the NIH-funded training program in Environmental Health Sciences and the NCI-funded Cancer Education Program. Dr. Hein previously served as the founding director of the Minority Biomedical Research Support Program at Morehouse School of Medicine and chaired Departments of Pharmacology & Toxicology at Morehouse School of Medicine and the University of North Dakota School of Medicine and Health Sciences prior to his appointment at UofL in 1997. He was appointed as Chester Fritz Distinguished Professor at the University of North Dakota, has received outstanding teaching awards awarded by the medical school class at both Morehouse School of Medicine and the University of North Dakota, the President's Faculty Achievement Award at Morehouse School of Medicine, the Thomas J. Clifford Faculty Achievement Award for Excellence in Research and the Burlington Northern Faculty Achievement Award for Excellence in Teaching, Research, and Creative Activity both from the University of North Dakota, an Outstanding Alumnus Award from the University of Michigan, the President's Award from the University of Wisconsin-Eau Claire, and the President's Outstanding Scholarship, Research and Creative Activity in Basic and Applied Sciences Award from the University of Louisville. He presented the Astor Visiting Lectureship at the University of Oxford (UK) and serves as a Visiting Professor at the Université Paris Diderot (France) and Wenzhou Medical University (P.R. China). He has been elected to membership in the Academy of Pharmacology Educators of the American Society for Pharmacology and Experimental Therapeutics and has served on many government and industry review panels. His research interests span pharmacogenetics and genomics, particularly arylamine N-acetyltransferases, molecular epidemiology, cancer prevention and education funded continuously since 1983 by grants totaling over $31M from the National Institutes of Health and other federal and private agencies. He has co-authored over 200 peer-reviewed journal articles and book chapters, 75 gene sequences, and over 500 abstracts that have received over 8500 citations (h-index=45) in the scientific literature. In addition to teaching and training graduate, professional, undergraduate and postgraduate students, he directs the Pharmacology and Dental Therapeutics course in the UofL School of Dentistry.